Private-equity deal highlights Atrium’s ambitions

Private-equity deal highlights Atrium’s ambitions

4 December 2013 - Deborah Wilkes

The news that Atrium Innovations is set to be acquired by a group of investors, including private-equity firm Permira, highlights the desire of the Canadian vitamins, minerals and supplements (VMS) company to continue expanding through both organic growth and acquisitions.

This NEWS EXTRA publication from OTCToolbox is designed to give you an insight into Atrium's current strategy. Make sure your team is well informed through a Multiple User Licence or a Global Licence.

Almost 2,000 words long, this nine-page NEWS EXTRA provides details of the proposed deal involving Permira, as well as Atrium's recent acquisitions, the company's business strategy and its financial performance. The publication also looks at Atrium's approach to innovation and its entry strategies for Brazil and Russia.

RAPID INSIGHTS MADE EASY

AVAILABLE TO DOWNLOAD IMMEDIATELY
 AS A PDF
See Payment Options box on this page



This NEWS EXTRA is also available as part of an Annual Subscription to the OTCToolbox website (click here to find out more).

For alternative payment options and delivery methods, or other questions, please send an email to enquiries@otctoolbox.com.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to News Extras

Share this page: